Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks

Biologicals. 2020 Nov:68:112-121. doi: 10.1016/j.biologicals.2020.07.003. Epub 2020 Sep 11.

Abstract

Influenza is an acute respiratory infection caused by the influenza virus, and vaccination against influenza is considered the best way to prevent the onset and spread. MDCK (Madin-Darby canine kidney) cells are typically used to isolate the influenza virus, however, their high tumorigenicity is the main controversy in the production of influenza vaccines. Here, MDCK-C09 and MDCK-C35 monoclonal cell lines were established, which were proven to be low in tumorigenicity. RNA-seq of MDCK-C09, MDCK-C35, and MDCK-W73 cells was performed to investigate the putative tumorigenicity mechanisms. Tumor-related molecular interaction analysis of the differentially expressed genes indicates that hub genes, such as CUL3 and EGFR, may play essential roles in tumorigenicity differences between MDCK-C (MDCK-C09 and MDCK-C35) and MDCK-W (MDCK-W73) cells. Moreover, the analysis of cell proliferation regulation-associated molecular interaction shows that downregulated JUN and MYC, for instance, mediate increased proliferation of these cells. The present study provides a new low-tumorigenic MDCK cell line and describes the potential molecular mechanism for the low tumorigenicity and high proliferation rate.

Keywords: MDCK cells; Molecular interactions; Monoclonal technique; Tumorigenicity.

MeSH terms

  • Animals
  • Cell Line
  • Cell Transformation, Neoplastic / genetics*
  • Clone Cells / metabolism*
  • Clone Cells / virology
  • Dogs
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation, Neoplastic*
  • Gene Regulatory Networks / genetics*
  • HeLa Cells
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology
  • Influenza A Virus, H1N1 Subtype / physiology
  • Influenza Vaccines / immunology
  • Influenza Vaccines / metabolism
  • Madin Darby Canine Kidney Cells
  • Mice, Nude
  • Virus Cultivation / methods

Substances

  • Influenza Vaccines